vaccinia/fowl pox TRICOM vaccine (Therion)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namevaccinia/fowl pox TRICOM vaccine (Therion)

Drug Alias Namepox virus TRICOM cancer vaccine (Therion/NCI)rV-TRICOMrF-TRICOMVF-TRICOM

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHead and Neck NeoplasmsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTherion Biologics Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTherion Biologics Corp

Active IndicationsN/A

Inactive IndicationsHead and Neck NeoplasmsMelanoma

Other Information

ATC CodeN/A